Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Folic Acid
Xijing Hospital
Stroke
1 trial -
Folic Acid
Hospital Authority, Hong Kong
Pregnant Women
1 trial -
Follitropin Beta;MSD
Reproductive & Genetic Hospital of CITIC-Xiangya
Infertility
1 trial -
Forced administration of furosemide
The First People's Hospital of Lianyungang
Cytoreductive Surgery
1 trial -
Fosinopril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Fruquintinib and Everolimus
The First People's Hospital of Lianyungang
Renal Cell Carcinoma, Clear Cell, Somatic
1 trial -
Fuzheng 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Immune Deficiency Syndrome Virus
1 trial -
Fuzheng 3
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Immune Deficiency Syndrome Virus
1 trial -
G-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intrauterine Adhesion
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GDMT
The First People's Hospital of Lianyungang
Heart Failure With Preserved Ejection Fraction
1 trial -
GLP-1 Receptor Agonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Short Bowel Syndrome (SBS)
1 trial -
Gabapentin
Hospital Authority, Hong Kong
Spinal Fusion
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gastrografin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
CRE-induced SBO
1 trial -
Gefitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
Genotype detected through GenSeizer high-throughput gene capture technology
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non - Tuberculosis Mycobacteria Lung Disease
1 trial -
Ginkgo Biloba Extract
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Glycerine Magnesium sulphate paste
Hospital Authority, Hong Kong
Infection
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Infertility, Female
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Clinical Pregnancy Rate
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources